1. Home
  2. RIGL vs NOA Comparison

RIGL vs NOA Comparison

Compare RIGL & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • NOA
  • Stock Information
  • Founded
  • RIGL 1996
  • NOA 1953
  • Country
  • RIGL United States
  • NOA Canada
  • Employees
  • RIGL N/A
  • NOA N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • NOA Meat/Poultry/Fish
  • Sector
  • RIGL Health Care
  • NOA Consumer Staples
  • Exchange
  • RIGL Nasdaq
  • NOA Nasdaq
  • Market Cap
  • RIGL 537.6M
  • NOA 478.5M
  • IPO Year
  • RIGL 2000
  • NOA 2006
  • Fundamental
  • Price
  • RIGL $41.64
  • NOA $13.53
  • Analyst Decision
  • RIGL Buy
  • NOA
  • Analyst Count
  • RIGL 6
  • NOA 0
  • Target Price
  • RIGL $39.83
  • NOA N/A
  • AVG Volume (30 Days)
  • RIGL 652.5K
  • NOA 93.7K
  • Earning Date
  • RIGL 11-04-2025
  • NOA 11-12-2025
  • Dividend Yield
  • RIGL N/A
  • NOA 2.47%
  • EPS Growth
  • RIGL 2698.26
  • NOA N/A
  • EPS
  • RIGL 6.20
  • NOA 0.91
  • Revenue
  • RIGL $282,076,000.00
  • NOA $922,043,377.00
  • Revenue This Year
  • RIGL $59.93
  • NOA $12.11
  • Revenue Next Year
  • RIGL N/A
  • NOA $6.50
  • P/E Ratio
  • RIGL $6.77
  • NOA $15.02
  • Revenue Growth
  • RIGL 79.13
  • NOA 8.06
  • 52 Week Low
  • RIGL $14.63
  • NOA $12.12
  • 52 Week High
  • RIGL $43.72
  • NOA $22.08
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 69.25
  • NOA 41.15
  • Support Level
  • RIGL $34.00
  • NOA $13.15
  • Resistance Level
  • RIGL $39.56
  • NOA $15.52
  • Average True Range (ATR)
  • RIGL 2.36
  • NOA 0.65
  • MACD
  • RIGL 1.09
  • NOA -0.15
  • Stochastic Oscillator
  • RIGL 91.70
  • NOA 13.07

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: